Menu
← Oncology Approval Tracker
FDA DECISION ·
Yervoy + Opdivo
ipilimumab with nivolumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
The Yervoy label gained an indication for adults with unresectable or metastatic melanoma treated with ipilimumab in combination with nivolumab.
LAMPGEN ANALYSIS
Why it matters
The 2021 action adds the existing checkpoint combination to the ipilimumab label.
What research teams should watch
Record the application and action date independently from the earlier nivolumab label action.
PRIMARY RECORDS